Meliane (Ethinylestradiol, Gestodene)

Ethinylestradiol mimics natural estrogen, while gestodene acts as a progestogen. Together they suppress the hypothalamic‑pituitary‑ovarian axis, lowering luteinizing hormone and follicle‑stimulating hormone levels, which prevents ovulation. The progestogen also thickens cervical mucus and alters the endometrium, creating an environment that hinders fertilisation and implantation.

The specific dosing regimen for Meliane is determined by the prescribing clinician. Typically, the medication is taken as one oral tablet each day at the same time, but the exact schedule and any missed‑dose instructions should be confirmed with the prescriber.

Meliane is contraindicated in pregnancy (pregnancy category X) and must be stopped immediately if pregnancy is confirmed. It is generally not recommended during breastfeeding because hormonal contraceptives can affect milk production and infant exposure; alternative methods should be discussed with a healthcare provider.

To order Meliane, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Meliane contains a third‑generation progestogen (gestodene) combined with ethinylestradiol, offering a low‑dose hormonal profile that may reduce androgenic side effects such as acne. Compared with older formulations, it provides similar contraceptive efficacy while potentially improving cycle control, but individual response and risk profiles should be evaluated by a clinician.

Meliane tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct light, and ensure they are out of reach of children. Do not store in bathrooms or other humid environments.

Meliane is taken orally as a single tablet each day, preferably at the same time each day to maintain steady hormone levels. The tablet should be swallowed whole with water and not chewed or broken. Consistent daily intake is essential for optimal contraceptive effectiveness.

Serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial events such as stroke or myocardial infarction, and rare hepatic tumors. Women should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe headache, visual changes, or abdominal pain.

Meliane should not be used by women who are pregnant, have a known hypersensitivity to any component, have a history of thromboembolic disorders, uncontrolled hypertension, certain cardiovascular diseases, active liver disease, or who smoke heavily and are over 35 years of age. A thorough medical assessment is required before initiating therapy.